Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and High-dose Chemotherapy with PBSC Rescue for Relapsed/Resistant Hodgkin's Disease
NCT00388349Phase 2Completed
- Sponsor
- Stanford University
- Start
- Sep 2001
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in Hodgkin lymphoma (HL), sponsored by Stanford University. Started Sep 2001; status: completed.
02
Drugs
gemcitabine
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00388349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00388349.